FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2685673622> ?p ?o ?g. }

• W2685673622 endingPage "07" @default.
• W2685673622 startingPage "01" @default.
• W2685673622 abstract "Background: The number of antiviral studies using plant extracts has increased in the last decades, and the results have shown that plants are potential sources of compounds that are able to inhibit and/or decrease viral infections. The selection of these plants by ethnopharmacological criteria increases the probability of fi nding new substances with signifi cant pharmacological and biological activities. Hence, Brazil has an advantage in this area due to its extensive biodiversity and ethnological diversity. Guettarda angelica is a plant from the Brazilian Caatinga region the roots of which are popularly used for various therapeutic purposes, including veterinary use. The aim of this work was to investigate the in vitro antiviral activity of extracts of plant parts from G. angelica against three animal herpesviruses: bovine (BoHV-1), suid (SuHV-1) and equine (EHV-1) herpesviruses type 1. Materials, Methods & Results: The extracts of roots, leaves and seeds of G. angelica were initially screened for in vitro antiviral activity against these herpesviruses using the virus yield reduction assay. The MDBK cells were used in assays with BoHV-1 and SuHV-1, and the Vero cells with EHV-1. For these assays, the cells previously treated with the extracts in non-cytotoxic concentrations were inoculated with logarithmic dilutions of each virus. The viral inhibitory activity of extracts was calculated by difference of virus titer between treated infected cells and non-treated infected cells. Only the aqueous extract from seeds (AEs) showed a signifi cant antiviral activity (P < 0.01, ANOVA followed by Tukey test) against all herpesviruses leading continuous studies. Thus, the selectivity index (SI) of this extract was determined by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] colorimetric assay by calculating the ratio CC50 over IC50. The 50% cytotoxic concentration (CC50) was defi ned as the extract concentration that reduced the cell viability by 50% when compared to untreated controls; the 50% inhibitory concentration (IC50) was defi ned as the concentration of the extract that inhibited 50% of viral replication when compared to the virus control. The CC50 and IC50 were obtained from nonlinear regression analysis of concentration-effect curves by the GraphPad Prism 5 Demo program and represented the means ± standard deviation of three independent experiments. The CC50 for Vero cells was 400.60 ± 0.20 µg/mL, while the CC50 for MDBK cells was 920.50 ± 0.19 µg/mL. The IC50 values of the AEs on the BoHV-1, SuHV-1 and EHV-1 were 22.79 µg/mL, 91.30 µg/mL and 19.95 µg/mL, respectively. The SI values of this extract for each virus obtained from these data were 40.39, 10.08 and 20.08 for BoHV-1, SuHV-1, and EHV-1, respectively. Discussion: To ensure the antiviral activity of a plant extract and consequently its future use as antiviral agent is crucial the obtainment of its selectivity index or safety index. It is guarantee of a true antiviral effect and not the result of cytotoxicity of the extract on cells, and that could be confused with an antiviral activity. Other important point are the extract IC50 values less than 100 µg/mL. The results of the AEs of G. angelica are in accordance with these considerations indicating that the G. angelica seeds may be a potential source of antiviral compounds insurance and encouraging further investigation of them." @default.
• W2685673622 created "2017-06-30" @default.
• W2685673622 creator A5020894962 @default.
• W2685673622 creator A5029347052 @default.
• W2685673622 creator A5049705749 @default.
• W2685673622 creator A5064802613 @default.
• W2685673622 creator A5065679634 @default.
• W2685673622 creator A5075204840 @default.
• W2685673622 creator A5079706934 @default.
• W2685673622 date "2012-12-01" @default.
• W2685673622 modified "2023-10-02" @default.
• W2685673622 title "Avaliação in vitro do potencial antiviral de Guettarda angelica contra herpesvírus animais" @default.
• W2685673622 cites W1523747266 @default.
• W2685673622 cites W1562059139 @default.
• W2685673622 cites W1948973457 @default.
• W2685673622 cites W1963506876 @default.
• W2685673622 cites W1963822376 @default.
• W2685673622 cites W1973487174 @default.
• W2685673622 cites W198128083 @default.
• W2685673622 cites W1992251391 @default.
• W2685673622 cites W1997958925 @default.
• W2685673622 cites W2010262406 @default.
• W2685673622 cites W2024921515 @default.
• W2685673622 cites W2039680908 @default.
• W2685673622 cites W2065883537 @default.
• W2685673622 cites W2087543526 @default.
• W2685673622 cites W2088931089 @default.
• W2685673622 cites W2099861412 @default.
• W2685673622 cites W2110837175 @default.
• W2685673622 cites W2115579826 @default.
• W2685673622 cites W2163254642 @default.
• W2685673622 cites W2163446105 @default.
• W2685673622 cites W2242624610 @default.
• W2685673622 hasPublicationYear "2012" @default.
• W2685673622 type Work @default.
• W2685673622 sameAs 2685673622 @default.
• W2685673622 citedByCount "1" @default.
• W2685673622 countsByYear W26856736222021 @default.
• W2685673622 crossrefType "journal-article" @default.
• W2685673622 hasAuthorship W2685673622A5020894962 @default.
• W2685673622 hasAuthorship W2685673622A5029347052 @default.
• W2685673622 hasAuthorship W2685673622A5049705749 @default.
• W2685673622 hasAuthorship W2685673622A5064802613 @default.
• W2685673622 hasAuthorship W2685673622A5065679634 @default.
• W2685673622 hasAuthorship W2685673622A5075204840 @default.
• W2685673622 hasAuthorship W2685673622A5079706934 @default.
• W2685673622 hasConcept C159047783 @default.
• W2685673622 hasConcept C202751555 @default.
• W2685673622 hasConcept C2522874641 @default.
• W2685673622 hasConcept C32611913 @default.
• W2685673622 hasConcept C55493867 @default.
• W2685673622 hasConcept C556039675 @default.
• W2685673622 hasConcept C71924100 @default.
• W2685673622 hasConcept C86803240 @default.
• W2685673622 hasConcept C89138240 @default.
• W2685673622 hasConcept C96529984 @default.
• W2685673622 hasConceptScore W2685673622C159047783 @default.
• W2685673622 hasConceptScore W2685673622C202751555 @default.
• W2685673622 hasConceptScore W2685673622C2522874641 @default.
• W2685673622 hasConceptScore W2685673622C32611913 @default.
• W2685673622 hasConceptScore W2685673622C55493867 @default.
• W2685673622 hasConceptScore W2685673622C556039675 @default.
• W2685673622 hasConceptScore W2685673622C71924100 @default.
• W2685673622 hasConceptScore W2685673622C86803240 @default.
• W2685673622 hasConceptScore W2685673622C89138240 @default.
• W2685673622 hasConceptScore W2685673622C96529984 @default.
• W2685673622 hasIssue "4" @default.
• W2685673622 hasLocation W26856736221 @default.
• W2685673622 hasOpenAccess W2685673622 @default.
• W2685673622 hasPrimaryLocation W26856736221 @default.
• W2685673622 hasVolume "40" @default.
• W2685673622 isParatext "false" @default.
• W2685673622 isRetracted "false" @default.
• W2685673622 magId "2685673622" @default.
• W2685673622 workType "article" @default.